| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth Sall | |
| Stephen Cohen | |||
| Anna Martin | |||
| P2860 | cites work | Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need. | Q51796037 |
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007) | Q80347916 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study | Q83540737 | ||
| Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management | Q83809653 | ||
| Patient-reported symptoms in dry dye disease | Q36561690 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| The challenge of dry eye diagnosis | Q37233339 | ||
| Etiology, prevalence, and treatment of dry eye disease | Q37288773 | ||
| Systane lubricant eye drops in the management of ocular dryness | Q37900496 | ||
| Evaluation of dry eye. | Q38021053 | ||
| Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye. | Q39244614 | ||
| Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study | Q43155971 | ||
| Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | Q43482891 | ||
| The repeatability of clinical measurements of dry eye. | Q44845090 | ||
| Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). | Q46469927 | ||
| An objective approach to dry eye disease severity | Q48343172 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 157-164 | |
| P577 | publication date | 2013-12-31 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose | |
| P478 | volume | 8 |
| Q35094304 | An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| Q90479106 | Evaluation of artificial tears on cornea epithelium healing |
| Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q58713024 | Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q50039889 | [Novel current and future therapy options for treatment of dry eye disease]. |
Search more.